Variable | No. observations (n = 400) § | Streptococcus pneumoniae | Staphylococcus aureus | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. isolates (n = 100)φ | OR [95% CI] | p | Adjusted OR [95% CI] | p | No. isolates (n = 114)λ | OR [95% CI] | p | Adjusted OR [95% CI] | p | ||
Group | |||||||||||
 CLD- | 18% (74) | 17% (17) | Reference |  | Reference |  | 18% (21) | Reference |  | Reference |  |
 CLD+ | 82% (326) | 83% (83) | 1.2 [0.6–2.1] | 0.66 | 1.3 [0.6–2.6] | 0.52 | 82% (93) | 1.0 [0.6–1.8] | 0.98 | 1.0 [0.5–1.8] | 0.92 |
Study site | |||||||||||
 Malawi | 27% (108) | 13% (13) | Reference |  | Reference |  | 18% (21) | Reference |  | Reference |  |
 Zimbabwe | 73% (292) | 87% (87) | 3.1 [1.7–6.1] | <0.001 | 3.1 [1.4–7.3] | 0.01 | 82% (93) | 1.9 [1.2–3.4] | 0.02 | 2.1 [1.1–4.2] | 0.04 |
Sex | |||||||||||
 Female | 52% (207) | 52% (52) | Reference |  | Reference |  | 50% (57) | Reference |  | Reference |  |
 Male | 48% (193) | 48% (48) | 1 [0.6–1.6] | 0.95 | 0.9 [0.6–1.5] | 0.73 | 50% (57) | 1.1 [0.7–1.7] | 0.66 | 1.1 [0.7–1.8] | 0.57 |
Season of sample collection | |||||||||||
 Dec–Apr - Rainy | 36% (143) | 26% (26) | Reference |  | Reference |  | 32% (37) | Reference |  | Reference |  |
 May–Aug - Cool | 39% (157) | 41% (41) | 1.6 [0.9–2.8] | 0.03 | 1.6 [0.9–3.0] | 0.04 | 37% (42) | 1.1 [0.6–1.8] | 0.25 | 1.1 [0.6–1.8] | 0.27 |
 Sep–Nov - Hot | 25% (100) | 33% (33) | 2.2 [1.2–4.1] | 2.3 [1.2–4.4] | 31% (35) | 1.5 [0.9–2.7] | 1.6 [0.9–2.8] | ||||
Enrolment age category | |||||||||||
 17-19y | 33% (130) | 38% (38) | Reference |  | Reference |  | 39% (45) | Reference |  | Reference |  |
 13-16y | 40% (161) | 39% (39) | 0.8 [0.5–1.3] | 0.34 | 0.8 [0.5–1.4] | 0.38 | 38% (43) | 0.7 [0.4–1.1] | 0.15 | 0.7 [0.4–1.2] | 0.25 |
 6-12y | 27% (109) | 23% (23) | 0.7 [0.4–1.2] | 0.6 [0.3–1.2] | 23% (26) | 0.6 [0.3–1.0] | 0.6 [0.3–1.1] | ||||
Number of years on ART | |||||||||||
 6 m- < 2y | 9% (35) | 12% (12) | Reference |  | Reference |  | 9% (10) | Reference |  | Reference |  |
 2- < 4y | 18% (71) | 21% (21) | 0.8 [0.3–1.9] | 0.39 | 0.6 [0.2–1.5] | 0.04 | 17% (19) | 0.9 [0.4–2.3] | 0.83 | 0.7 [0.3–1.8] | 0.57 |
 4y- < 6y | 20% (79) | 19% (19) | 0.6 [0.3–1.5] | 0.4 [0.2–1.0] | 23% (26) | 1.2 [0.5–3.0] | 0.9 [0.4–2.4] | ||||
 6y+ | 53% (208) | 47% (47) | 0.6 [0.3–1.2] | 0.3 [0.1–0.8] | 51% (58) | 1 [0.5–2.2] | 0.6 [0.3–1.6] | ||||
CD4 count | |||||||||||
  > 500 | 63% (251) | 63% (63) | Reference |  |  |  | 59% (67) | Reference |  |  |  |
 200–500 | 28% (110) | 26% (26) | 0.9 [0.5–1.6] | 0.81 |  |  | 32% (36) | 1.3 [0.8–2.2] | 0.51 |  |  |
  < 200 | 10% (38) | 11% (11) | 1.2 [0.6–2.5] |  |  | 10% (11) | 1.1 [0.5–2.3] |  |  | ||
Enrolment viral load | |||||||||||
 Unsuppressed | 42% (169) | 35% (35) | Reference |  |  |  | 47% (54) | Reference |  | Reference |  |
 Suppressed | 58% (231) | 65% (65) | 1.5 [0.9–2.4] | 0.09 | 1.4 [0.8–2.3] | 0.22 | 53% (60) | 0.8 [0.5–1.2] | 0.19 | 0.7 [0.4–1.1] | 0.09 |
ART regimen | |||||||||||
 PI-based regimen - 2nd line | 24% (98) | 27% (27) | Reference |  | Reference |  | 25% (28) | Reference |  | Reference |  |
 NNRTI-based regimen -1st line | 76% (302) | 73% (73) | 0.9 [0.5–1.5] | 0.57 | 1.1 [0.6–2.1] | 0.75 | 75% (86) | 1 [0.6–1.7] | 0.947 | 1.2 [0.7–2.2] | 0.54 |
Ever treated for TB | |||||||||||
 No | 74% (294) | 65% (65) | Reference |  | Reference |  | 72% (82) | Reference |  | Reference |  |
 Yes | 26% (104) | 35% (35) | 1.8 [1.1–2.9] | 0.02 | 1.8 [1.0–3.2] | 0.04 | 28% (32) | 1.2 [0.7–1.9] | 0.58 | 1.0 [0.6–1.8] | 0.92 |
Enrolment weight- for-age- z-score | |||||||||||
 Not underweight | 54% (217) | 61% (61) | Reference |  |  |  | 54% (61) | Reference |  |  |  |
 Underweight | 46% (183) | 39% (39) | 0.7 [0.4–1.1] | 0.12 |  |  | 46% (53) | 1.0 [0.7–1.6] | 0.85 |  |  |
Enrolment height-for-age- z-score - | |||||||||||
 Not stunted | 55% (218) | 59% (59) | Reference |  | Reference |  | 58% (66) | Reference |  | Reference |  |
 Stunted | 46% (182) | 41% (41) | 0.8 [0.5–1.2] | 0.3 | 0.9 [0.5–1.5] | 0.64 | 42% (48) | 0.8 [0.5–1.3] | 0.39 | 0.8 [0.5–1.3] | 0.46 |
Ever repeated a grade | |||||||||||
 No | 46% (180) | 49% (49) | Reference |  |  |  | 47% (54) | Reference |  |  |  |
 Yes | 54% (211) | 51% (50) | 0.8 [0.5–1.3] | 0.43 |  |  | 53% (60) | 0.9 [0.6–1.4] | 0.74 |  |  |
MRC dyspnoea score | |||||||||||
 1 or 0 | 60% (240) | 68% (67) | Reference |  | Reference |  | 65% (73) | Reference |  | Reference |  |
  > 1 | 40% (159) | 32% (32) | 0.7 [0.4–1.0] | 0.079 | 0.9 [0.5–1.7] | 0.86 | 35% (40) | 0.8 [0.5–1.2] | 0.25 | 1.1 [0.6–2.0] | 0.67 |